Arthrex SCOTUS Oral Arguments on Monday! We’ll Be Live Tweeting Updates

Sterne, Kessler, Goldstein & Fox P.L.L.C.

When oral arguments commence in United States v. Arthrex, Inc., No. 19-1434 (U.S.) on Monday, March 1, William H. Milliken, a director in Sterne Kessler’s Trial & Appellate Practice Group, will be live tweeting updates from the firm’s account, @sternekessler. Updates will begin at 10:00 a.m. and continue throughout the duration of the proceedings.

By way of background, in October 2020, the U.S. Supreme Court granted certiorari in Arthrex v. Smith & Nephew to review the Federal Circuit's decision regarding the constitutionality of the appointment of USPTO Patent Trial and Appeal Board (PTAB) judges. Our October 14, 2020, client alert outlined analysis from Milliken highlighting what practitioners and litigants should know as the Supreme Court considers this case.

The firm will continue to provide updates and analysis on this case up to the Court’s decision and beyond.

Note: Sterne, Kessler, Goldstein & Fox filed an amicus brief on behalf of TiVo Corporation in support of Arthrex in this case.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sterne, Kessler, Goldstein & Fox P.L.L.C. | Attorney Advertising

Written by:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Sterne, Kessler, Goldstein & Fox P.L.L.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.